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All cells are equipped to sense changes in their environment and make adaptive 
responses according to the stimuli. Signal recognition usually occurs at the cell membrane 
(with the exception of steroid signalling) where the ligand, which can be a small molecule, a 
peptide or a protein, binds its cognate receptor. This results in a change in the conformation 
of the receptor which in turn can regulate the production of second messengers. Second 
messengers can now modulate specific pathways which control gene expression and modify 
various aspects of cell behaviour. The signalling cascade is terminated by the removal of 
second messenger and/or by desensitisation of the receptor to the extracellular signal.  
Cyclic guanosine monophosphate (cGMP) was first identified in the rat urine and 
since then has emerged as an important second messenger regulating diverse cell 
processes. Subsequent to its discovery in mammalian cells, enzymes responsible for its 
synthesis (guanylyl cyclases), hydrolysis (phosphodiesterases) and its most common 
effectors (cGMP-dependent protein kinases) were identified. Guanylyl cyclases exist in two 
forms, cytosolic and membrane bound. Both have a conserved guanylyl cyclase domain, but 
differ in their choice of ligands, overall structure and tissue localization. It is now known that 
cytosolic and the membrane-bound forms are involved in eliciting distinct cellular 
responses. 
Receptor guanylyl cyclase C (GC-C) was identified as the target for a family of heat-
stable enterotoxin toxins (ST) produced by enterotoxigenic E.coli.  Stable toxin-mediated 
diarrhoeas are observed frequently in infants and contribute significantly to the incidence of 
Travellers’ Diarrhea.  Early studies demonstrated that the effects of ST were mediated by an 
increase in intracellular cGMP levels in intestinal cells, and the receptor for ST was almost 
exclusively expressed in the apical microvilli of the intestinal brush-border epithelia. 
Effectors of cGMP in intestinal cells include protein kinase G (PKG), cyclic nucleotide gated 
ion channel 3 (CNG), and the cystic fibrosis transmembrane conductance regulator (CFTR). 
ST is an exogenous ligand which serves as a hyperagonist for GC-C, in comparison with the 
endogenous ligands guanylin and uroguanylin, which maintain fluid-ion homeostasis in the 
intestinal epithelia. The GC-C/cGMP signal transduction pathway also modulates intestinal 
cell proliferation along the crypt-villus axis by exerting a cytostatic effect on the epithelial 
cells, thereby regulating their turnover and neoplastic transformation.  
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The current study describes in molecular detail two signalling pathways, one 
impinging on and one emerging from GC-C, which regulate colonic cell proliferation. The 
first part identifies the cross-talk and cross-regulation of GC-C and c-src. The second part 
delves into the molecular basis of GC-C/cGMP-mediated cytostasis and its effect on colonic 
tumorigenesis. 
Cross-talk between signalling pathways is believed to play a key role in regulating 
cell physiology. Phosphorylation of signalling molecules by protein kinases is frequently 
used as a means of achieving this cross-regulation. Aberrant hyperactivation of the c-src 
tyrosine kinase is an early event in the progression of colorectal cancer, and activated c-src 
specifically phosphorylates a number of proteins in the cell. It was found that c-src can 
phosphorylate GC-C in T84 colorectal carcinoma cells, as well as in the rat intestinal 
epithelia. Tyrosine phosphorylation of GC-C resulted in attenuation of ligand-mediated 
cGMP production; an effect which was reversed by chemical or transcriptional knockdown of 
c-src. These effects were found to be cell line-independent and relied only on the extent of 
c-src expression and activation in the cell.  
Mutational analysis revealed GC-C to be phosphorylated on a conserved tyrosine 
residue (Y820) in the guanylyl cyclase domain. The sequence of GC-C around Y820 allowed 
for efficient phosphorylation by c-src, and indeed, kinase assays indicated that the affinity of 
c-src for the GC-C Y820 peptide was one of the highest reported till date. A phospho-
mimetic mutation at this site, which mimics a constitutively phosphorylated receptor, 
resulted in a sharp reduction of guanylyl cyclase activity of the receptor, reiterating the 
inhibitory role of Y820 phosphorylation on GC-C activity. Phosphorylation of GC-C at Y820 
generated a docking site for the SH2 domain of c-src which could interact and thereby co-
localize with GC-C on the cell membrane. Intriguingly, this interaction resulted in activation 
of c-src, setting-up a feed-forward loop of inhibitory GC-C phosphorylation and c-src 
activation. 
Treatment of colorectal carcinoma cells with ligands for GC-C reduces cell 
proliferation and inhibits tumorigenesis. It was observed that this cytostatic effect can be 
modulated by the status of c-src activation, and consequently, the fraction of tyrosine 
phosphorylated GC-C in these cells.  Since activation of c-src is a frequent event in intestinal 
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neoplasia, phosphorylation of GC-C by active c-src may be one of the means by which the 
cytostatic effects of GC-C agonists (guanylin and uroguanylin) in the intestine are bypassed, 
thereby leading to cancer progression.  
Colonisation of the gut with enteropathogenic microorganisms induces secretion of 
IFN from the host mucosal immune system, which subsequently activates c-src in intestinal 
epithelial cells. Ligand-stimulated activity of GC-C was found to be reduced in IFN treated 
cells. This could be one of the host defence mechanisms initiated in response to 
enterotoxigenic E. coli infection. These results provide the first evidence of cross-talk 
between a receptor guanylyl cyclase and a tyrosine kinase that results in heterologous 
desensitisation of the receptor. 
Populations with a higher incidence of enterotoxigenic E.coli infections appear to be 
protected from intestinal neoplasia. It was found that mice lacking GC-C, and therefore 
unable to respond to ST, displayed an increased cell proliferation in colonic crypts and 
enhanced carcinogen-induced aberrant crypt foci formation, which is a surrogate marker for 
colorectal carcinogenesis. However, pharmacological elevation of cGMP was able to 
efficiently induce cytostasis even in GC-C knockout mice, indicating a key role for cGMP in 
regulating colonic cell proliferation. Through microarray analyses, genes regulated by ST-
induced GC-C activation in T84 colorectal carcinoma cells were identified. Genes involved in 
a number of cellular pathways were differentially expressed, including those involved in 
signal transduction, protein and solute secretion, transcriptional regulation and extracellular 
matrix formation. One of the genes found to be significantly up-regulated was the cell-cycle 
inhibitor, p21. The increase in p21 expression was validated at both the transcript and 
protein level. This p53-independent up-regulation of p21 was coupled to the activation of 
the cGMP-responsive kinase, PKGII, since knockdown of PKGII using specific siRNAs 
abolished ST-induced p21 induction. Activation of PKGII led to phosphorylation and 
activation of the stress responsive p38 MAPK. Similar to what was seen following 
knockdown of PKGII, inhibition of p38 MAPK activity attenuated the up-regulation of p21 in 
response to cGMP, indicating that PKGII and p38 MAPK could be a part of a pathway 
regulating p21 expression. It was found that active p38 MAPK phosphorylated the 
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ubiquitous transcription factor SP1, enhancing its occupancy at the proximal p21 promoter. 
Therefore, SP1 could be one of the factors linking cGMP to transcription of the p21 mRNA.  
Chronic activation of GC-C led to nuclear accumulation of p21 in colonic cells, which 
entered a quiescent state. These cells arrested in the G1 phase of the cell cycle, consequent 
to p21-dependent inhibition of the G1 cyclin-CDK complexes. A fraction of these quiescent 
cells stochastically initiated a cGMP-dependent senescence programme and displayed all 
the hallmarks of senescent cells, including flattened cell morphology, expression of SA- 
galactosidase and formation of senescence-associated heterochromatic foci. Activation of 
senescence and loss of tumorigenicity in these cells was crucially dependent on the up-
regulation of p21. This irreversible exit from the cell cycle due to cGMP-mediated activation 
of the PKGII/p38/p21 axis was well correlated with reduced colonic polyp formation in mice 
exposed to ST.  
In summary, these observations may provide a possible explanation for the low 
incidence of colorectal carcinoma seen in countries with a high incidence of ST-mediated 
diarrhoea. Interestingly, c-src mediated tyrosine phosphorylation of GC-C prevented p21 
accumulation following ligand application. The findings described in this thesis may have 
important implications in understanding the molecular mechanisms involved in the 
progression and treatment of colorectal cancer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
